Blood biomarkers and Ki-67 proliferation marker in breast cancer
Metastasis is the leading cause of death in patients with breast cancer (BC). It is known that the lesion of regional lymph nodes by tumor cells is more common in tumors with higher proliferative activity. Moreover, there is literature evidence on effects of cytokines and proteins upon the migration...
Saved in:
Main Authors: | A. A. Studenikina, E. S. Mikhaylova, S. A. Arkhipov, N. A. Varaksin, A. V. Proskura, A. I. Autenshlyus |
---|---|
Format: | Article |
Language: | Russian |
Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2023-04-01
|
Series: | Медицинская иммунология |
Subjects: | |
Online Access: | https://www.mimmun.ru/mimmun/article/view/2570 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Biomarkers of Proliferation and Inflammation (Ki67, p53, and COX-2) in Actinic Keratoses with Photodynamic Therapy
by: Justyna Ceryn, et al.
Published: (2025-06-01) -
Characterization and analysis of Ki-67-immunoreactivity in brain astrocytoma
by: Shpon‘ka I.S., et al.
Published: (2016-03-01) -
BIOLOGICAL MARKERS OF THE Ki-67 CELL CYCLE AND Bcl-2 IN MYOMA, ADENOMYOSIS, AND LEIOMYOSARCOMA UTERI
by: Светлана Владимировна Шрамко, et al.
Published: (2019-09-01) -
PROGNOSTIC AND PREDICTIVE SIGNIFICANCE OF KI67 DYNAMIC CHANGE DURING PREOPERATIVE ENDOCRINE THERAPY IN BREAST CNACER PATIENTS
by: M. V. Rodionova, et al.
Published: (2016-02-01) -
Characterization and analysis of Ki-67-immunoreactivity in brain astrocytoma.
by: I. S. Shpon‘ka, et al.
Published: (2016-04-01)